Skip to main content

Transcatheter Pulmonary Valve Replacement clinical trials at UCSF

1 research study open to eligible people

Showing trials for
  • ALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent

    open to all eligible people

    To demonstrate the safety and effectiveness of the Edwards Alterra Adaptive Prestent in conjunction with the Edwards SAPIEN 3 Transcatheter Heart Valve (THV) System in subjects with a dysfunctional right ventricular outflow tract/pulmonary valve (RVOT/PV) who are indicated for treatment of pulmonary regurgitation (PR). Following completion of enrollment, subjects will be eligible for enrollment in the continued access phase of the trial.

    San Francisco, California and other locations

Last updated: